Explainer
Does Naltrexone Make You Sleepy or Tired?
By Naltrexone Reviews Editorial TeamUpdated 14 sourcesHow we check

On this page
Short answer
Daytime sleepiness is one of the naltrexone side effects seen more often than on placebo: about 9 more people per 100 in pooled alcohol trials.1 Trouble sleeping was also more common on the 50 mg tablet, and sleep problems after stopping drinking can last for weeks.2,3
Key takeaways
- Compare each figure with its own placebo group. In the trials in our table, sleepiness on placebo ran from 4% to 38%.2
- On the 380 mg Vivitrol shot, tiredness affected 23% of people against 12% on a placebo shot; sleepiness or sedation, 4% against 1%.4
- The naltrexone tablet label names no time of day to take it. If the timing seems to be the problem, that is a question for your prescriber.5
- Very drowsy with slow breathing after using opioids is an emergency, not a side effect to wait out.4
Sleepiness and insomnia are both more common than on placebo
In a safety study of about 570 people taking naltrexone tablets for alcohol, 4% had new tiredness, 3% insomnia and 2% sleepiness.5,6 That study had no placebo group.6 In placebo-controlled trials, the 2010 Cochrane review counted sedation, along with stomach upset, among naltrexone's main side effects: about 9 more people per 100 had daytime sleepiness than on placebo (95% CI, 5 to 14).1 A 2019 review pooled 12-week trials of 50 mg a day. In 4 trials with 529 people, the odds of daytime sleepiness were 1.85 times those on placebo (95% CI, 1.19-2.87). In 4 trials with 514 people, the odds of insomnia were 1.99 times (95% CI, 1.16-3.39).2 Almost all of these data come from people reporting side effects rather than sleep-lab measurements.2
| Trial | Dose | Symptom | On naltrexone | On placebo |
|---|---|---|---|---|
| Anton 1999 | 50 mg | Daytime sleepiness | 46% | 27% |
| O'Malley 2008 | 50 mg | Sleepiness | 35% | 26% |
| Kranzler 2000 | 50 mg | Sleepiness; trouble sleeping | 48%; 59% | 38%; 40% (neither gap significant) |
| Gastpar 2002 | 50 mg | Sleepiness | 6% | 4% (not significant) |
| COMBINE (Anton 2006) | 100 mg | Somnolence | 37% | 24%7 |
| Oslin 2008 | 100 mg | Insomnia | 24% | 12% |
| Vivitrol alcohol trials | 380 mg shot, monthly | Tiredness; sleepiness or sedation; insomnia or sleep disorder | 23%; 4%; 14% | 12%; 1%; 12%4 |
Sleepiness and insomnia are both more common than on placebo
Trial: Anton 1999
- Dose
- 50 mg
- Symptom
- Daytime sleepiness
- On naltrexone
- 46%
- On placebo
- 27%
Trial: O'Malley 2008
- Dose
- 50 mg
- Symptom
- Sleepiness
- On naltrexone
- 35%
- On placebo
- 26%
Trial: Kranzler 2000
- Dose
- 50 mg
- Symptom
- Sleepiness; trouble sleeping
- On naltrexone
- 48%; 59%
- On placebo
- 38%; 40% (neither gap significant)
Trial: Gastpar 2002
- Dose
- 50 mg
- Symptom
- Sleepiness
- On naltrexone
- 6%
- On placebo
- 4% (not significant)
Trial: COMBINE (Anton 2006)
- Dose
- 100 mg
- Symptom
- Somnolence
- On naltrexone
- 37%
- On placebo
- 24%7
Trial: Oslin 2008
- Dose
- 100 mg
- Symptom
- Insomnia
- On naltrexone
- 24%
- On placebo
- 12%
Trial: Vivitrol alcohol trials
- Dose
- 380 mg shot, monthly
- Symptom
- Tiredness; sleepiness or sedation; insomnia or sleep disorder
- On naltrexone
- 23%; 4%; 14%
- On placebo
- 12%; 1%; 12%4
Source: the 2019 review's table of included trials, plus the Vivitrol label for the shot.2 The COMBINE row matches the trial's own adverse-event table: 112 of 309 people on naltrexone alone and 72 of 309 on placebo, with each group pooled across the behavioral-therapy arms.7 COMBINE and Oslin 2008 used 100 mg, twice the 50 mg label dose for alcohol.5 The label's all-doses column for the shot (5% sleepiness) includes 190 mg and 400 mg groups.4 See Vivitrol side effects.
Early sobriety disrupts sleep too
Sleep recovers only partly in the first 30 days without alcohol.8 Insomnia after stopping drinking can last weeks to years, so if you started naltrexone and stopped drinking in the same week, either change could be making you tired.3
It tends to start early; how long it lasts is barely studied
Reports collected after the tablet's approval show that most side effects "usually occur early in the course of drug therapy and are transient."5 The VA/DoD guideline says side effects tend to appear early and can typically resolve within 1 to 2 weeks after a dose adjustment.9 Neither gives a day count for sleepiness.
The one duration figure in these sources comes from a small trial of older adults (44 people). Sleep problems were about as common on placebo (38%) as on naltrexone (35%), but lasted 2.9 weeks on average on naltrexone and 1.4 weeks on placebo; the review marks the result not significant.2 Tell your doctor if drowsiness is severe or does not go away.10 The wider early-weeks timeline is on how long naltrexone takes to work.
Alcohol feels more sedating on naltrexone
In human laboratory studies of drinking on naltrexone, alcohol felt more sedating than on placebo (18 studies, 777 people), though the effect was small.11 What else changes when you drink on it is on naltrexone and alcohol.
When tiredness is a warning sign
- Very drowsy with slowed breathing, or faint and confused, after using opioids. These are overdose signs: call 911. Naloxone can reverse an opioid overdose, but call 911 even if it is given.4 The overdose risk after stopping naltrexone is covered on naltrexone side effects.
- Tired or sleepy all the time, sleeping much more or less than usual, or feeling sad and losing interest in things. The Vivitrol Medication Guide lists each of these as a depression sign that needs a call to your provider right away.4 For thoughts of self-harm, call or text 988.12
- Tiredness with dark urine, yellowing eyes or stomach pain lasting more than a few days. These can be signs of liver injury.4,10
- Taking thioridazine. Lethargy and sleepiness have been reported with the combination.5
Both labels advise against driving or using heavy machinery until you know how naltrexone affects you, because it can cause dizziness.4,5
Low-dose naltrexone and Contrave have their own sleep effects
Low-dose naltrexone (LDN), an off-label use: in one research group's LDN trials, about 37% of participants reported more vivid dreams, and a minority had nightmares. Vivid dreams were also the most common complaint while those participants took placebo, so expectation may explain some cases.13 See low-dose naltrexone side effects.
Contrave, a weight-loss pill that combines naltrexone with bupropion, had insomnia in 9.2% of people against 5.9% on placebo in trials of the combination.14 See naltrexone and bupropion (Contrave).
Your experience: If naltrexone changed how you sleep, you can share your story. Stories appear on naltrexone reviews only with permission.
Frequently asked questions
Does drowsiness from naltrexone go away?
Side effects usually come early and pass; in one small trial, sleep problems on naltrexone lasted about 3 weeks on average. See it tends to start early.2,5
Should I take naltrexone at night or in the morning?
MedlinePlus says to take the tablet at about the same time each day, with or without food; neither label names a time, and we found no trial comparing morning and evening doses of the 50 mg tablet. If you are drowsy in the day or sleep badly, ask your prescriber whether a different time would suit you; in research on off-label LDN, usually taken about an hour before bed, some people with insomnia were moved to morning doses. Don't change your dose or stop on your own; dosing details are on naltrexone dosage.10,13
Can naltrexone cause insomnia or vivid dreams?
Yes: insomnia odds were about twice those on placebo in 4 trials of the 50 mg tablet; vivid dreams are common on off-label low-dose naltrexone, though also on placebo. See low-dose naltrexone and Contrave and LDN side effects.2,13
Does naltrexone have a calming effect?
Naltrexone is not labelled or sold as a calming drug or a sleep aid, and nervousness (4%) and anxiety (2%) are on the same 570-person side-effect list as sleepiness. See the numbers.5
How we checked
Related guides
References
14 sources, numbered in the order they are first cited (AMA style). Each is labelled by type so you can weigh it; commercial and media sources are never the only support for a clinical claim.
- 1.Rösner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M. Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev. 2010;(12):CD001867. doi:10.1002/14651858.CD001867.pub3Systematic review / meta-analysis · Our summary of this study
- 2.Panin F, Peana AT. Sleep and the pharmacotherapy of alcohol use disorder: unfortunate bedfellows. A systematic review with meta-analysis. Front Pharmacol. 2019;10:1164. doi:10.3389/fphar.2019.01164Systematic review / meta-analysis · Our summary of this study
- 3.Roehrs TA, Auciello J, Tseng J, Whiteside G. Current and potential pharmacological treatment options for insomnia in patients with alcohol use disorder in recovery. Neuropsychopharmacol Rep. 2020;40(3):211-223. doi:10.1002/npr2.12117Narrative review
- 4.Vivitrol (naltrexone for extended-release injectable suspension). Prescribing information and Medication Guide. Alkermes, Inc.; revised May 2026. DailyMed SPL version 39. Accessed October 17, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cd11c435-b0f0-4bb9-ae78-60f101f3703fFDA drug label
- 5.Naltrexone hydrochloride tablets USP, 50 mg. Prescribing information. SpecGx LLC; revised May 2026. DailyMed SPL version 15. Accessed October 17, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06ff2d5a-e62b-4fa4-bbdb-01938535bc65FDA drug label
- 6.Croop RS, Faulkner EB, Labriola DF. The safety profile of naltrexone in the treatment of alcoholism: results from a multicenter usage study. Arch Gen Psychiatry. 1997;54(12):1130-1135. doi:10.1001/archpsyc.1997.01830240090013Research study · Our summary of this study
- 7.Anton RF, O'Malley SS, Ciraulo DA, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006;295(17):2003-2017. doi:10.1001/jama.295.17.2003Randomized controlled trial · Our summary of this study
- 8.Koob GF, Colrain IM. Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework. Neuropsychopharmacology. 2020;45(1):141-165. doi:10.1038/s41386-019-0446-0Narrative review
- 9.US Department of Veterans Affairs; US Department of Defense. VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders. Version 5.0. 2021. Accessed October 17, 2026. https://www.healthquality.va.gov/HEALTHQUALITY/guidelines/MH/sud/VA-DoD-SUD-CPG_Final_for-508_v3.pdfClinical guideline
- 10.Naltrexone. MedlinePlus. US National Library of Medicine. Updated September 15, 2026. Accessed October 17, 2026. https://medlineplus.gov/druginfo/meds/a685041.htmlGovernment source
- 11.Ray LA, Green R, Roche DJO, Magill M, Bujarski S. Naltrexone effects on subjective responses to alcohol in the human laboratory: a systematic review and meta-analysis. Addict Biol. 2019;24(6):1138-1152. doi:10.1111/adb.12747Systematic review / meta-analysis · Our summary of this study
- 12.988 Suicide & Crisis Lifeline. Accessed October 17, 2026. https://988lifeline.org/Nonprofit organization
- 13.Younger J, Parkitny L, McLain D. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin Rheumatol. 2014;33(4):451-459. doi:10.1007/s10067-014-2517-2Narrative review
- 14.Contrave (naltrexone hydrochloride and bupropion hydrochloride) extended-release tablets. Prescribing information. Nalpropion Pharmaceuticals LLC; revised November 2025. DailyMed SPL version 27. Accessed October 17, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=485ff360-32c8-11df-928b-0002a5d5c51bFDA drug label
Medical disclaimer
This page is for general information only and is not medical advice. It does not replace advice from your own clinician or pharmacist. Don't start, stop or change a medicine or dose without talking to your prescriber. If you are physically dependent on alcohol, stopping suddenly can be dangerous; get medical advice first. If you use opioids, starting naltrexone in either form can cause sudden, severe withdrawal.
Full medical disclaimer.